Features associated with cardiac abnormalities in systemic lupus erythematosus

Lupus

Volumn 20, Issue 14, 2011, Pages 1518-1525

  Bourre Tessier J ^a   Huynh, T ^a   Clarke, A E ^a,b   Bernatsky, S ^a,b   Joseph, L ^b   Belisle, P ^b   Pineau, C A ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

cardiovascular disease; systemic lupus erythematosus; ultrasonography

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOSUPPRESSIVE AGENT; NITRIC ACID DERIVATIVE;

ADULT; AGING; AORTA VALVE REGURGITATION; ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HEART DISEASE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; LABORATORY DIAGNOSIS; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; PERICARDIAL EFFUSION; PREVALENCE; PRIORITY JOURNAL; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HEART VALVE DISEASES; HEART VALVES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED;

EID: 82955189318     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311420318     Document Type: Article

References (24)

1. Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum. 1987 ; 17: 126-141 (Pubitemid 18028173)
2. Mosca M, Tani C, Aringer M, et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis. 2010 ; 69: 1269-1274
3. Wajed J, Ahmad Y, Durrington PN, Bruce IN. Prevention of cardiovascular disease in systemic lupus erythematosus-proposed guidelines for risk factor management. Rheumatology (Oxford). 2004 ; 43: 7-12 (Pubitemid 38088360)
4. Farzaneh-Far A, Roman MJ, Lockshin MD, et al. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 3918-3925 (Pubitemid 44955895)
5. Amoroso A, Cacciapaglia F, De Castro S, et al. The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement. Clin Exp Rheumatol. 2006 ; 24: 287-294 (Pubitemid 44151148)
6. Perez-Villa F, Font J, Azqueta M, et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: A prospective, long-term, follow-up study. Arthritis Rheum. 2005 ; 53: 460-467 (Pubitemid 40799888)
7. Prabu A, Patel K, Yee CS, et al. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford). 2009 ; 48: 1506-1511
8. Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol. 1992 ; 20: 1127-1134
9. Gleason CB, Stoddard MF, Wagner SG, Longaker RA, Pierangeli S, Harris EN. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J. 1993 ; 125: 1123-1129 (Pubitemid 23117348)
10. Shahin AA, Shahin HA, Hamid MA, Amin MA. Cardiac involvement in patients with systemic lupus erythematosus and correlation of valvular lesions with anti-Ro/SS-A and anti-La/SS-B antibody levels. Mod Rheumatol. 2004 ; 14: 117-122 (Pubitemid 40796172)
11. Wranicz JK, Cygankiewicz I, Zielinska M, Woåniacka A, Sysa-Jedrzejowska A. Non-invasive cardiac evaluation in patients with systemic lupus erythematosus. J Med. 2001 ; 32: 195-206 (Pubitemid 32899513)
12. Omdal R, Lunde P, Rasmussen K, Mellgren SI, Husby G. Transesophageal and transthoracic echocardiography and Doppler examinations in systemic lupus erythematosus. Scand J Rheumatol. 2001 ; 30: 275-281 (Pubitemid 32980340)
13. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277 (Pubitemid 13221242)
14. Bombardier C, Gladman DD, Urowitz M, Caron D, Chang CH. Derivation of the SLEDAI: A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
15. Gladman DD, Urowitz MB, Goldsmith CH, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 809-813 (Pubitemid 27199995)
16. Hartley RM, Velez R, Morris RW, D'Souza MF, Heller RF. Confirming the diagnosis of mild hypertension. Br Med J (Clin Res Ed). 1983 ; 28: 287-289 (Pubitemid 13149377)
17. Quiñones MA, Douglas PS, Foster E, et al. ACC/AHA clinical competence statement on echocardiography: A report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence. J Am Coll Cardiol. 2003 ; 41: 687-708 (Pubitemid 36230921)
18. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009 ; 53: 1573-1619
19. Singh JP, Evans JA, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham heart study). Am J Cardiol. 1999 ; 83: 897-902 (Pubitemid 29143128)
20. Roldan CA. Valvular and coronary heart disease in systemic inflammatory diseases: Systemic Disorders in heart disease. Heart. 2008 ; 94: 1089-1101 (Pubitemid 352039899)
21. Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Revisiting Libman-Sacks endocarditis: A historical review and update. Clin Rev Allergy Immunol. 2009 ; 36: 126-130
22. Cefle A, Inanc M, Sayarlioglu M, et al. Pulmonary hypertension in systemic lupus erythematosus: Relationship with antiphospholipid antibodies and severe disease outcome. Rheumatol Int. 2009 ;:
23. Palmieri V, Migliaresi P, Orefice M, et al. High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index. Nutr Metab Cardiovasc Dis. 2009 ; 19: 234-240
24. Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum.. 2001 ; 44: 2331-2337